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Abstract
The human gastric pathogen Helicobacter pylori causes chronic gastritis, peptic ulcer disease, gastric
carcinoma, and mucosa-associated lymphoid tissue (MALT) lymphoma. It infects over 50% of the
worlds' population, however, only a small subset of infected people experience H. pylori-associated
illnesses. Associations with disease-specific factors remain enigmatic years after the genome
sequences were deciphered. Infection with strains of Helicobacter pylori that carry the cytotoxin-
associated antigen A (cagA) gene is associated with gastric carcinoma. Recent studies revealed
mechanisms through which the cagA protein triggers oncopathogenic activities. Other candidate
genes such as some members of the so-called plasticity region cluster are also implicated to be
associated with carcinoma of stomach. Study of the evolution of polymorphisms and sequence
variation in H. pylori populations on a global basis has provided a window into the history of human
population migration and co-evolution of this pathogen with its host. Possible symbiotic
relationships were debated since the discovery of this pathogen. The debate has been further
intensified as some studies have posed the possibility that H. pylori infection may be beneficial in
some humans. This assumption is based on increased incidence of gastro-oesophageal reflux
disease (GERD), Barrett's oesophagus and adenocarcinoma of the oesophagus following H. pylori
eradication in some countries. The contribution of comparative genomics to our understanding of
the genome organisation and diversity of H. pylori and its pathophysiological importance to human
healthcare is exemplified in this review.
Introduction
Helicobacter pylori is a bacterium that colonizes the harshly
acidic milieu of the human stomach. More than half of
the world's population carries this infection. Infection
rates vary among the developed and developing countries
of the world. H. pylori infection is on a steep decline in
most of the western countries mainly due to the success of
combination therapies and improved personal hygiene
and community sanitation to prevent re-infection. How-
ever, the situation is not improving in many of the devel-
oping countries due to failure of treatment regimes and
emergence of drug resistance. The infection in some cases
leads to chronic superficial gastritis, chronic active gastri-
tis, peptic ulcer disease and gastric adenocarcinoma [1-4].
One of the most distinctive features of H. pylori is the
genetic diversity between clinical isolates obtained from
different patient populations. Most H. pylori isolates can
be discriminated from others by DNA profiling [5-8] or
sequencing of corresponding genes due to mainly a high
degree of sequence divergence between orthologs (3–5%)
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[9,10]. Also, H. pylori has a panmictic or freely recombin-
ing population structure [11] and is naturally competent
[12]. These characteristics facilitate an inter-strain recom-
bination due mainly to horizontal exchange of alleles
from other strains colonising the same niche, which is
extremely common in H. pylori chromosome. However,
such genetic recombinations in the H. pylori genome
might not be deleterious because they occur in the plastic-
ity zone, a special cluster of DNA rearrangements that pro-
tects the essential complement of genes by acting as a bed
for foreign DNA insertion or abrogation. DNA loss and
rearrangement are therefore a norm for H. pylori, and flex-
ibility and diversity in gene content may contribute to
bacterial fitness in different members of the diverse
human host population. Post genomic analyses have
revealed interesting attributes of H. pylori pathogenicity
and novel mechanisms of causation of ulcer disease and
cancer have been envisaged. Efforts to know the cause and
potential benefits of the genetic diversity of this bacterium
has led to some interesting discoveries relating to its co-
evolution with the human host, microevolution while
during infection and quasi-species development, viru-
lence determinants and eradication strategies. Recent
studies reviewed herein collectively aim at testing the
speculation about whether H. pylori may be beneficial to
human health in certain circumstances and whether erad-
ication of this organism is always necessary? Epidemio-
logical studies are needed in the context of such intriguing
hypotheses. Results obtained from such studies might
enable the development of a high-throughput screening
system for high-risk groups within the huge population of
H. pylori-infected individuals. Recent studies have shown
that H. pylori infection protects against gastro-oesophageal
reflux and oesophageal carcinoma. So it will be important
to selectively eradicate H. pylori in people that are at the
highest risk of developing gastric carcinoma. Eradication
of highly pathogenic H. pylori specifically from high-risk
groups would markedly reduce the worldwide incidence
of ulcer and gastric cancer.
Epidemiology and Evolution
H. pylori infection is usually acquired during childhood,
where transmission occurs predominantly within families
[13]. A couple of recent studies demonstrated the possible
co-existence of a large array of clonal lineages within H.
pylori populations that are evolving in each individual sep-
arately from one another [14,10]. It is therefore probable
that via this semi-vertical transmission of H. pylori strains,
there are distinct sets of H. pylori genotypes colonising dif-
ferent human populations. With different strains evolving
separately of one another and the fact that H. pylori is a
genetically diverse (panmictic) organism, distinct geno-
types have been found to be associated with particular
geographic regions [15,16]. For example, the shuffling of
variant regions within the vacA gene (a gene encoding a
vacuolating cytotoxin) within a local H. pylori population
has led to predominant vacA genotypes being characteris-
tic of isolates from different geographic regions. In addi-
tion, worldwide studies encompassing H. pylori isolates
from many geographic regions have demonstrated weak
clonal groupings and geographic partitioning of H. pylori
isolates [9,17]. If recombination only occurs between a
resident  H. pylori population, exchange of genetic
sequences can genetically homogenise this population. As
H. pylori is naturally competent and recombination occurs
frequently [11], specific genotypes associated with differ-
ent geographic regions occur as a result of this homogenis-
ing force.
Introduction of polymorphisms and sequence variants
from one H. pylori population from a particular geo-
graphic region to another H. pylori population from
another geographic region via human migration makes
the association of particular genotypes with specific geo-
graphic locations more difficult. Although the introduc-
tion of new polymorphisms into a particular H. pylori
population poses a problem with identifying specific gen-
otypes within certain geographic locales, it may, however,
provide information on the ancestry of the hosts in whose
stomachs the strains were carried. Studies have been
aimed at demonstrating the path of human migration to
Latin America with conflicting results regarding whether
European or Asian populations brought H. pylori to South
America [16,11]. However, a recent and comprehensive
study by Flaush et al. [19] demonstrated that sequence
analysis of H. pylori isolates recovered from twenty-seven
countries displayed geographic partitioning. Thus, poly-
morphisms within the H. pylori genome can serve as use-
ful markers for studying ancient human migrations.
However, a mix up of H. pylori strains between migrated
and native populations can sometimes complicate analy-
sis. Accordingly, the study of migrated populations that
have remained isolated from the native populations is
essential.
Genome organization, genetic diversity and microevolution
Since its successful isolation in 1983 by Warren and Mar-
shall, H. pylori has been linked to various pathologies and
a strong association with gastric carcinoma and mucosa-
associated lymphoid tissue lymphoma [1,3] has been
established. However, although H. pylori is definitely
responsible for these diseases, only less than 10% of peo-
ple colonized with H. pylori portray disease symptoms.
This suggests that specific H. pylori strains may be respon-
sible for virulence in different hosts. Many studies have
shown that certain allotypes of the vacA gene and the pres-
ence a functional cagA  gene are associated with an
increased risk of peptic ulceration and gastric cancer,
respectively [20-22]. However, these correlations vary
based on the host population studied and efforts toAnnals of Clinical Microbiology and Antimicrobials 2005, 4:1 http://www.ann-clinmicrob.com/content/4/1/1
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correlate other H. pylori alleles with clinical diseases have
failed.
So how do a few H. pylori strains trigger higher virulence
as compared to other strains? Current approaches in func-
tional genomics based on protein- protein interaction and
microarray based transcription profiling are helping to
decode this mystery. Functional genomics often uses the
gene chip based expression profiling to provide a condi-
tion-dependent and time-specific genome wide profile of
an organism's transcriptome [23,24]. Whereas, compara-
tive genomics juxtaposes two or more genome sequences
at the level of gene content and organization [25,26].
Both the approaches harness extensive computer algo-
rithms and in silico modelling to summarise gene encoded
(or putative) functions. H. pylori has been the first
prokaryote wherein full genome sequence of two different
patient isolates [J99 and 26995] were characterized and
compared [27,28]. As H. pylori is a freely recombining or
panmictic organism [11] the question of whether the two
genome sequences would accurately represent the myriad
of genetic diversity found among the strains was posed.
Since the 2 sequenced strains were obtained a decade
apart from the two different continents and cultured from
the lesions of different gastric disorders, it has been widely
assumed that their genome sequences will more likely
portray the genetic diversity exhibited by clinical isolates.
Comparative genomic analysis of the two completely
sequenced strains revealed a significant amount of genetic
variation between their genomes. For instance, the J99
genome is shorter (1,643,831 bp) than that of strain
26695 (1,667,867 bp) and has 57 less predicted ORF's
[27,28]. Strains 26695 and J99 contain 110 and 52 strain
specific genes, respectively [29,30], in which more than a
half reside within a locus termed the plasticity cluster. A
recent approach helped revised annotation and compari-
son of the two sequenced H. pylori genomes [31] and
reclassified the coding sequences. Based on this study the
total number of hypothetical proteins was reduced from
40% to 33%. A large amount of size variation was also dis-
covered between orthologous genes mostly due to natural
polymorphisms arising as a result of natural transforma-
tion and free recombination within H. pylori chromo-
some. Recombinational events including the presence of
insertion elements, pathogenicity islands, horizontally
acquired genes (restriction recombination genes), mosa-
ics and chromosomal rearrangements were frequently
annotated in subsequent bioinformatics based attempts.
It has been argued that such diversity is a result of a lack
of direct competition between strains, even when resident
within different individuals within the same community
[32]. However, a recent study has demonstrated that inte-
gration of foreign gene fragments acquired via natural
transformation is often prevented by the well-developed
restriction-modification systems in H. pylori genome [33].
It has been demonstrated that H. pylori has extensive, non-
randomly distributed repetitive chromosomal sequences,
and that recombination between identical repeats con-
tributes to the variation within individual hosts [34]. That
H. pylori is representative of prokaryotes, especially those
with smaller (<2 megabases) genomes, that have similarly
extensive direct repeats, suggests that recombination
between such direct DNA repeats is a widely conserved
mechanism to promote genome diversification [33]. In
addition, although H. pylori has been termed as a panmic-
tic organism [11,35], it is surprising that clonal lineages
within H. pylori populations exist [36-39]. Recent reports
demonstrated that H. pylori in some populations shows a
clonal descent and suggest that a large array of H. pylori
clonal lineages co-exist, which evolve in isolation from on
another [14]. Moreover, in certain parts of the world H.
pylori isolates have been shown to exhibit little genetic
heterogeneity, based on fingerprint profiles [17,40]. Func-
tional genomics, utilising microarray technology, has pro-
vided researchers with a powerful tool to investigate the
genetic diversity of clinical isolates [41], the transcrip-
tional profiles of isolates grown under different condi-
tions [42], the identification of strain-specific and species-
specific genes [29,30] and the diversity between strains
giving rise to differing clinical illnesses [43]. One of the
interesting findings using microarray based genotyping
has been the discovery that H. pylori isolates undergo
'microevolution' and give rise to sub-species during pro-
longed colonisation of a single host [44-46]. The presence
of stable sub-species within a single individual suggests an
adaptation of a H. pylori population to specific host
niches, facilitated by unknown advantages conferred to
them by select plasticity region genes. Bjorkholm et al.
[45] demonstrated that several loci differed within two
genetically related isolates from the same host, one major
difference being the presence of the cag  pathogenicity
island (cag PAI) in one isolate and not the other. As the
cagA  gene and cag  PAI are principle virulence factors
within the strains, the excision or abrogation of the cag
PAI within a strain may indicate that attenuating the viru-
lence of a strain could be a favourable adaptation.
The conundrum of strain diversity: How many more genome 
sequences do we need to understand this bug?
Within the bacterial populations, genome content may
not be fixed, as changing selective forces favour particular
phenotypes; however, organisms well adapted to particu-
lar niches may have evolved mechanisms to facilitate such
plasticity. The highly diverse H. pylori is a model for stud-
ying genome plasticity in the colonization of individual
hosts. For H. pylori, neither point mutation, nor intergenic
recombination requiring the presence of multiple colo-
nizing strains, is sufficient to fully explain the observed
diversity.Annals of Clinical Microbiology and Antimicrobials 2005, 4:1 http://www.ann-clinmicrob.com/content/4/1/1
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The two H. pylori genomes sequenced to date are each
from ethnic Europeans, and genomic comparisons mod-
elled on these data are sufficient to identify novel loci
from new strains, especially from understudied Asian
populations. However, these genome sequences may not
be fully representative of the entire diversity of the gene
pool. Identification and characterization of such loci
which are more abundant in the Asian gene pool may lead
to newer insights into the mechanisms of H. pylori coloni-
zation, carriage and virulence in the countries of Asia
which are more seriously under threat from H. pylori.
Therefore, future high throughput efforts involving a large
number of strains are clearly needed. Taking the Indian
example for instance, according to the Ethnologue data-
base http://www.ethnologue.com, there are about 1683
languages and dialects ('mother tongues') in this country
and H. pylori diversity therefore can be assumed to coin-
cide with this figure. So one has to roughly look at the
inter-strain genomic diversity contributed by approxi-
mately 1683 different strains representing each dialect
and or a community.
Nonetheless, genotypic data from each geographic area or
a community is extremely vital and might constitute a
missing piece of a large, biologic jigsaw puzzle.
Natural competence and transformation
Independent of the other two pathogenesis associated
type IV systems, H. pylori harbours a dedicated type IV
apparatus, the comB gene cluster [47] linked to the natu-
ral transformation and competence. The comB gene cluster
is essential for the bacterium to take up plasmid and chro-
mosomal DNA during natural transformation. To identify
the genes essential for natural transformation competence
in H. pylori, genetic approach of transposon shuttle muta-
genesis has been used and the comB locus was located,
consisting of orf2 and comB1-comB3 [48,49]. This cluster
contains four tandemly arranged genes, ORF2, comB1,
comB2 and comB3 as a single transcriptional unit. Subse-
quently, the components of comB cluster namely Orf2,
comB1, comB2 and comB3 were renamed (according to
homology with the Agrobacterium tumifaciens type IV
secretory apparatus) as comB7, comB8, comB9 and
comB10 respectively (Figure 1). Another ORF in
HP26695, HP0017 was found to be homologous to the
virB4 gene in Agrobacterium tumifaciens type IV secretory
apparatus and was named as comB4 [50]. From this study
it also appeared that each of the gene products of ORFs
comB8 to comB10 were absolutely essential for the devel-
opment of natural transformation competence. It appears
that the comB transformation apparatus has evolved con-
servatively and is typically present in all the strains. This
conservation is interestingly in agreement with the need
for genomic fluidity in H. pylori where deletions and rear-
rangements due to natural transformation and transposi-
tion are the norm. This is therefore necessary for the
pathogen to keep the gene content flexible and as diverse
as possible to probably acclimatise itself to diverse host
niches during the process of infection. Both these systems,
the cag-PAI encoded type IV export system and the trans-
formation-associated type IV system seem to act com-
pletely independently, since the deletion of one system
from the chromosome does apparently not affect the
function of the other system.
Pathogenic apparatuses
The cag pathogenicity island
Molecular analysis of bacterial transport has been
attempted in several bacterial pathogens. Among such
transport systems, Type IV secretion systems have been
described in greater detail in diverse bacteria. In H. pylori,
3 different kinds of type IV secretion apparatuses have
been identified. The first such secretion system identified
in H. pylori was the one comprised of 29 genes encoding
the cag pathogenicity island (cag-PAI). One of the princi-
pal virulence factors of H. pylori, the cagA antigen is con-
tained in the 40 kb cag-PAI. The tyrosine-phosphorylated
cagA protein is translocated to the epithelial cells by the
type IV secretion system (forming a sort of syringe like
structure) [51-53]. Upon tyrosine phosphorylation, the
cagA protein elicits growth factor like stimuli in epithelial
cells (hummingbird phenotype) coupled with inter-
leukin-8 induction for the recruitment of neutrophils.
Mutations in several genes of the cag-PAI interfere with
tyrosine phosphorylation and induction of interleukin-8
secretion [54]. In recent studies, in order to analyse which
genes of the cag-PAI are essential for cagA translocation
and/or interleukin 8 induction, a complete mutagenesis
of the cag-PAI was performed [55]. In general, it appears
that most of the cag genes are involved in assembly and
arrangement of the secretory apparatus. Five of these
genes namely HP0524 (virD4), HP0525 (virB11),
HP0527 (virB10), HP0528 (virB9) and HP0544 (virB4/
cagE) constitute the main apparatus of the type IV secre-
tory system of H. pylori [56]. All these genes except
HP0524 are associated with IL8 production [55]. How-
ever, the presence of strains eliciting IL 8 responses irre-
spective of intactness of the cag-PAI underlines the fact
that it's 'not' the only factor linked to IL8 secretion [57].
Very recently, and for the first time, ultrastructure analysis
of the surface of H. pylori 26695 has revealed a sheathed,
surface organelle, coded by the cag-PAI genes, HP0527
(forms sheath around the pilus needle) and HP0532/
cagT (forms the base of the pilus) [58]. This structure,
although uncommon, could be the special adaptation of
H. pylori to the host niches and this might mediate biolog-
ical as well as transport functions of the cag-PAI encoded
proteins. Computational analyses to predict the macro-Annals of Clinical Microbiology and Antimicrobials 2005, 4:1 http://www.ann-clinmicrob.com/content/4/1/1
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molecular assemblies of such apparatuses are needed to
have a more simplified understanding of the entire model
of the H. pylori type IV secretion mechanism
Link with cancer: the oncogenic cagA protein
A large-scale prospective study revealed that the risk for
development of gastric carcinoma was much greater in the
H. pylori-infected population than in the H. pylori-unin-
fected population [59]. The cagA  gene of H. pylori is
assumed as partially responsible for eliciting signaling
mechanisms that lead to the development of gastric aden-
ocarcinoma. Based on the carriage of a functional cagA as
a marker for the cag PAI, the H. pylori species is divided
into  cagA-positive and cagA-negative strains. The cagA-
positive strains are associated with higher grades of gastric
or duodenal ulceration and are more virulent than the
cagA-negative strains [60]. Some epidemiological studies
have demonstrated roles of cagA positive H. pylori in the
development of atrophic gastritis, peptic-ulcer disease and
gastric carcinoma [61,62]. The cagA gene product, cagA, is
translocated to the gastric epithelial cells to undergo tyro-
sine phosphorylation by SRC family kinases [63]. Tyro-
sine phosphorylation is known to occur at the EPIYA
motifs on the cagA. The cagA protein upon phosphoryla-
tion binds and activates a SHP2 phosphatase that acts as a
human oncoprotein. As SHP2 transmits positive signals
for cell growth and motility, deregulation of SHP2 by cagA
is an important mechanism by which cagA-positive H.
pylori promotes gastric carcinogenesis. Cag A is noted for
its variation at the SHP2 binding site and, based on the
Different outcomes of H. pylori infection Figure 1
Different outcomes of H. pylori infection. Some studies argue that eradication of H. pylori might trigger some of the worst forms 
of heart burns and increased acidity, leading ultimately to oesophageal cancer and or GERD.
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sequence variation, it is sub- classified into two main
types – East-Asian cagA and Western cagA. East-Asian cagA
shows stronger SHP2 binding and greater biological
activity than Western cagA. In East-Asian countries,
endemic circulation of H. pylori strains that carry biologi-
cally active forms of cagA might underlie the high inci-
dence of gastric carcinoma. One puzzling attribute of H.
pylori infection is why some populations with high inci-
dences of H. pylori infection, such as those in Japan and
Korea, have high incidences of gastric carcinoma, whereas
other highly infected populations, such as populations in
central Africa, do not. Possible reasons could be the differ-
ences in genetic susceptibility among populations, envi-
ronmental factors such as dietary habits, and strain
differences of H. pylori. Among these, diversity of cagA in
H. pylori strains might be involved in determination of the
type and severity of disease. As discussed above, East-
Asian and Western forms of cagA possess the distinctly
structured tyrosine phosphorylation/ SHP2-binding sites
– EPIYA-D and EPIYA-C, respectively [64]. Notably, the
grades of inflammation, activity of gastritis, and atrophy
are significantly higher in patients with gastritis who were
infected with the East-Asian cagA-positive strain than in
patients infected with the cagA-negative or Western cagA-
positive strain [65]. Furthermore, the prevalence of the
East-Asian cagA-positive strain is associated with the mor-
tality rate of gastric cancer in Asia. Therefore, populations
infected with East-Asian cagA  positive  H. pylori are at
greater risk for gastric cancer than those infected with
Western cagA-positive strains.
Among Western CagA species, the number of EPIYA-C
sites directly correlates with levels of tyrosine phosphor-
ylation, SHP2-binding activity and morphological trans-
formation [64]. Furthermore, molecular epidemiological
studies have shown that the number of EPIYA-C sites is
associated with the severity of atrophic gastritis and gastric
carcinoma in patients infected with Western CagA-posi-
tive strains of H. pylori [66].
The number-2 virulence determinant: vacuolating 
cytotoxin (VacA) of H. pylori
H. pylori has a single copy of the vacA gene. Screening of
H. pylori chromosomal fragments permitted the identifica-
tion of a 3864-base pair open reading frame (vacA) that
encoded the vacuolating cytotoxin [67]. The sequence of
the vacA gene includes a 33 amino acid signal sequence.
With the exception of a hydrophobic region at the N ter-
minus, the mature 90-kDa protein (amino acids 34 to
842) is mainly hydrophilic [67]. The cytotoxic activity of
VacA has been shown to increase substantially under
acidic conditions. VacA protein, a secreted 95 kD peptide,
varies in the signal sequence (alleles s1a, s1b, s1c, s2) and/
or its middle region (alleles m1, m2) between different H.
pylori  strains. The different combinations of s and m
regions determine the production of cytotoxic activity.
Strains with the genotype s1 m1 produce high levels of
vacuolating cytotoxin in vitro. Strains with the genotype
s2 produce an inactive toxin. Whereas, strains with the
genotype m2 produce toxic activity with a different target
cell specificity from those of m1 genotype. Genotypic var-
iations in the vacA gene structure specific to a geographic
locale have been recognised. While the vacA m1a allele is
specific for the European strains [16], the vacA m1b geno-
type is typical of the Asian strains [68]. Yet another signal
region genotype, s1c is also characteristic of the East
Asians [69]. Among other functions, VacA selectively
inhibits the invariant chain (Ii)-dependent pathway of
antigen presentation mediated by the MHC class II and
might induce apoptosis in epithelial cells. VacA, so far
mainly regarded as a cytotoxin of the gastric epithelial cell
layer, now turns out to be a potent immunomodulatory
toxin, targeting the adapted immune system. Thus, in
addition to the well-known vacuolating activity, VacA has
been reported to induce apoptosis in epithelial cells, to
affect B lymphocyte antigen presentation, to inhibit the
activation and proliferation of T lymphocytes, and to
modulate the T cell-mediated cytokine response.
The plasticity region cluster
The fascinating genomic landmark discovered post
genomic era in both the sequenced strains is the one
where 48% and 46% of the strain specific genes are
located in J99 and 26695 respectively. This region is called
as the 'plasticity zone' [28]. Genome sequence compari-
sons have revealed that nearly half of the strain specific
genes fall in this zone. Recently, a new type IV secretion
apparatus has been located in this plasticity zone [70].
This type IV cluster is comprised of 7 genes, homologous
to the vir B operon of A. tumifaciens carried in a 16.3 kb
genomic fragment called tfs3 (Figure 1). This cluster was
discovered by Kersulyte et al. as a result of subtractive
hybridization and chromosome walking and sequence
homology. They also tested conservation of this island in
clinical isolates and found that full length and partially
disrupted tfs3 occur in 20% and19% of the strains respec-
tively, from Spain, Peru, India and Japan. Although there
is no correct role assigned to this cluster, it might be an
unusual transposon linked to many deletion events occur-
ing in the plasticity region that contribute to bacterial fit-
ness in diverse host populations via exercising flexibility
in gene content and gene order. The plastic nature of H.
pylori  and the evidence of horizontal transfer of genes
from other H. pylori isolates and bacterial species could
explain the ability of this organism to persist in a changing
environment and why only a subset of clinical isolates
exert an adverse effect on patients.Annals of Clinical Microbiology and Antimicrobials 2005, 4:1 http://www.ann-clinmicrob.com/content/4/1/1
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Link with cancer: are plasticity region genes involved?
The plasticity region as a whole displays certain character-
istics of pathogenicity islands [71] with relatively low G+C
content (35%) compared to the rest of the genome
(39%). This region is about 45 kb long in J99 and 68 kb
long in strain 26695. Genomic analysis revealed the
region to be highly mosaic with a majority of the genes
being transcribed suggesting their functional role. They
also express protein level homology to various other
recombinases, integrases and topoisomerases [72]
accounting to natural transformation and recombination.
In addition to these, many ORFs were identified as differ-
entially expressed (JHP0927-JHP0928-JHP0931 and JHP-
042-JHP0944-JHP0945-JHP0947-JHP0960). They share
same chromosomal orientation and therefore they poten-
tially represent a bacterial operon. It is interesting to study
the expression or suppression of these ORFs in strains
linked to different clinical conditions. Recent studies have
posed a possibility to explore the presence of any new
pathogenicity markers in the plasticity zone, although the
functions of most of the putatively encoded proteins in
this cluster are unknown. But they are thought to play a
role in increasing the virulence capacity of H. pylori strains
either directly or by encoding factors that could lead to
variance in the clinical out come of the infection. More
interestingly, it is also noted that some of the genes of the
plasticity regions were co-inherited along with cagA. How-
ever their co-association with the disease status or with the
severity of gastric inflammation was not established either
due to small sample size or lack of clinical information
[73]. Interestingly, a novel pathogenicity marker, JHP947
has been detected within the plasticity zone [74]. Many
genes putatively linked to the development of gastric can-
cer have been assigned to the plasticity zone [72].
Researchers have looked for genetic markers in H pylori
strains isolated from patients with gastric extranodal mar-
ginal zone B cell lymphoma (MZBL) of the mucosa-asso-
ciated lymphoid tissue (MALT)-type and strains from age
matched patients with gastritis only [75]. Two ORFs were
significantly linked with gastric MZBL over gastritis
strains: JHP950 (74% v 49%) and JHP1462 (26% v 3%).
JHP950 proved specific for gastric MZBL when tested
against a group of strains from patients with duodenal
ulcer and patients with adenocarcinoma, with significant
prevalence (49% and 39%, respectively), and is therefore
the candidate marker for gastric MZBL. Interestingly, the
candidate ORF JHP950 is located in the plasticity region
of the J99 genome [75,76]. In view of such findings it can
be speculated that some members of the plasticity region
cluster provide selective advantage to some of the strains
to adapt to changing host niches and become more and
more invasive. In what way such advantage is gained? This
needs to be discovered.
Do we need to eradicate H. pylori from this earth?
How long humans carried H. pylori is still controversial.
However, it is accepted that this organism has colonized
humans possibly for many thousands of years, and the
successful persistence of H. pylori in human stomach for
such a long period may be because this organism offers
some advantages to the host. Unfortunately, the H. pylori
infection is on steep decline in the western world. This is
mainly due to the success rate of combination therapies
and subsequent prevention of re-infection due to
improvement in sanitation and personal hygiene. This
may seem good news to many gastro-enterologists around
the world, but having a H. pylori infection may be advan-
tageous. A study has shown that H. pylori produces a cecro-
pin-like peptide (antibacterial peptide) with high
antimicrobial properties [77]. A German study revealed
that children infected with H. pylori were less likely to have
diarrhoea than children without an infection [78], imply-
ing that H. pylori may have beneficial properties to human
hosts. Interestingly, there has been a marked decline in
the instances of peptic ulcer disease and gastric cancer in
the 20th  century. Concurrent with this is a dramatic
increase in the incidences of gastro-oesophageal reflux
disease (GERD), Barrett's oesophagus and adenocarci-
noma of the oesophagus in Western countries [79]. This
observation led to the speculation that H. pylori may in
some way be associated with these diseases and perhaps
capable of preventing their onset. Studies have also shown
that cagA+ H. pylori strains have a more protective effect
than  cagA- strains [80]. The presence of cagA+ H. pylori
strains can reduce the acidity of the stomach, and it is
believed that the raising of the pH by H. pylori prevents
GERD, Barrett's oesophagus and adenocarcinoma of the
oesophagus (Figure). Conversely, arguments have been
made that, although H. pylori may prevent these reflux-
associated diseases, the risks of acquiring gastric cancer via
H. pylori infection far outweigh any possible benefits it
may provide [81]. However, it has been stated that, if H.
pylori does provide protection from GERD, the notion of
restriction of anti-H. pylori treatment to only a few cases
(peptic ulcer disease and MALT lymphoma) could be jus-
tified [82]. In spite of this controversy, recent reports have
demonstrated a protective role for H. pylori in erosive
reflux oesophagitis [83-85]. However, as safe and potent
anitsecretory drugs to prevent gastro-oesophageal reflux
are available [86] it seems unjustified to use a dangerous
organism that has been associated with extremely danger-
ous outcomes such as a carcinoma.
On the other hand, eradication also is not an ultimate
choice. Some ulcers recur even after successful eradication
of H. pylori in non-users of non-steroidal anti-inflamma-
tory drug (NSAID). In addition, the incidence of H. pylori-
negative, non-NSAID peptic ulcer disease (PUD) (idio-
pathic PUD) is reported to increase with time. Moreover,Annals of Clinical Microbiology and Antimicrobials 2005, 4:1 http://www.ann-clinmicrob.com/content/4/1/1
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it appears that H. pylori-positive ulcers are not always H.
pylori-induced ulcers because there are two paradoxes of
the H. pylori myth, first the existence of H. pylori-positive
non-recurring ulcer and secondly, recurring ulcer after
cure of H. pylori infection. To summarise, H. pylori is not
the only cause of peptic ulcer disease. Therefore, it is still
necessary to seriously consider the need for eradication in
all cases of PUD, which may exist even after the elimina-
tion of H. pylori.
Conclusion and expert opinion
In our opinion, the intricacies of the role of H. pylori in
health and disease may be fully ascertained only if we ana-
lyze genetic diversity of the pathogen as juxtaposed to the
host diversity and the environment (food and dietary hab-
its). A possible working hypothesis (that we are currently
nurturing) may be that among the ocean of molecular
host-pathogen interactions that could potentially occur
with micro-evolution of this bacterium during long term
colonization, some could prove advantageous where the
bacterium and the host negotiate nearly a 'symbiotic' and
balanced relationship. Such a 'friendship' might have
taken thousands of years to develop. If so, why has this
bacterium survived for such a long time? Microbes that
have long been persisted in humans may be less harmful
than recently emerged microbes, such as the human
immunodeficiency viruses (HIV). This suggests that the
colonization may either be beneficial or of low biological
cost to the host. In addition to characterization of bacte-
rial virulence apparatuses that are for sure linked to dis-
ease outcome, host responses to such factors must also be
examined hand in hand, to completely ascertain mecha-
nisms that lead to gastroduodenal disease. For instance
polymorphisms linked to the host immune apparatus,
such as IL-1β, TNF-α, and IL-10, which are responsible for
elevated proinflammatory potential of the strains. These
polymorphisms increase the risk for atrophic gastritis and
distal gastric adenocarcinoma among H. pylori-infected
persons. Cancer of stomach is a highly lethal disease and
establishment of H. pylori as a risk factor for this malig-
nancy deserves an approach to identify persons at
increased risk; however, infection with this organism is
extremely common and most colonized persons never
develop cancer. Thus, screens to identify high-risk sub-
populations must use high-resolution biological markers.
Fortunately, this task appears to be highly simplified due
to the availability of biological tools, which were never
thought in the past. Genome sequences (H. pylori, human,
C. elegans), quantitative phenotypes (cagA phosphoryla-
tion, oipA frame status, vac Aallele status), and practical
animal models (Mongolian gerbils) can be harnessed to
decipher the molecular basis of H. pylori-associated malig-
nancies, which should have direct clinical applications. It
is important to gain more insight into the pathogenesis of
H. pylori-induced gastric adenocarcinoma, not only to
develop more effective diagnostics and treatment for this
common cancer, but also to validate the role of chronic
inflammation in the genesis of other tumours of the ali-
mentary tract.
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